Correlation Engine 2.0
Clear Search sequence regions


  • dna damage (1)
  • Eif2ak4 (1)
  • female (1)
  • Gcn2 (4)
  • gene (1)
  • insulin (12)
  • kinases (2)
  • liver (2)
  • long term effect (1)
  • mice (5)
  • mice knockout (1)
  • signal (1)
  • Sizes of these terms reflect their relevance to your search.

    Leucine deprivation improves insulin sensitivity; however, whether and how this effect can be extended are unknown. We hypothesized that intermittent leucine deprivation (ILD) might produce a long-term effect on improved insulin sensitivity via the formation of metabolic memory. Consistently, seven ILD cycles of treatment (1-day leucine-deficient diet, 3-day control diet) in mice produced a long-lasting (after a control diet was resumed for 49 days) effect on improved whole-body and hepatic insulin sensitivity in mice, indicating the potential formation of metabolic memory. Furthermore, the effects of ILD depended on hepatic general control nondepressible 2 (GCN2) expression, as verified by gain- and loss-of-function experiments. Moreover, ILD increased Gcn2 expression by reducing its DNA methylation at two CpG promoter sites controlled by demethylase growth arrest and DNA damage inducible b. Finally, ILD also improved insulin sensitivity in insulin-resistant mice. Thus, ILD induces long-lasting improvements in insulin sensitivity by increasing hepatic Gcn2 expression via a reduction in its DNA methylation. These results provide novel insights into understanding of the link between leucine deprivation and insulin sensitivity, as well as potential nutritional intervention strategies for treating insulin resistance and related diseases. We also provide evidence for liver-specific metabolic memory after ILD and novel epigenetic mechanisms for Gcn2 regulation. © 2022 by the American Diabetes Association.

    Citation

    Hanrui Yin, Feixiang Yuan, Fuxin Jiao, Yuguo Niu, Xiaoxue Jiang, Jiali Deng, Yajie Guo, Shanghai Chen, Qiwei Zhai, Cheng Hu, Yiming Li, Feifan Guo. Intermittent Leucine Deprivation Produces Long-lasting Improvement in Insulin Sensitivity by Increasing Hepatic Gcn2 Expression. Diabetes. 2022 Feb 01;71(2):206-218

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 34740902

    View Full Text